Navigation Links
Early Diagnosis Of Oral Cancer And Sjogren's Syndrome Possible By Saliva-Based Tests

Diagnosing oral cancer and Sjogren's syndrome using saliva-based tests will soon become a reality according to two studies presented at the yearly meeting of American Association for Dental Research.// Sjogren's syndrome is an autoimmune disorder that is characterized by dry eyes, dry mouth and rheumatoid arthritis. "If we can catch someone with oral cancer at stage 2 instead of stage 4, we can improve this person's 5-year survival rate by 50 percent, which would be of tremendous service not only to the quality of life of the individual, but also to the healthcare burden of the country," senior investigator Dr. David Wong said. Reserachers led by Dr Wong at the University of California in Los Angeles monitored 350 saliva samples from oral cancer patients and compared the same with healthy patients. It was found that seven "messenger RNAs," that are vital for building proteins were at a high level in oral cancer patients. Using this as a guideline, researchers had developed a test to detect oral cancer, which would be useful in screening people with high risk of developing the condition. In another study, Dr. Jane C. Atkinson and colleagues at the National Institute for Dental and Craniofacial Research in Bethesda, Maryland have shown that the saliva of patients with Sjogren's syndrome can be compared with that of healthy individuals to diagnose the condition. Sjogren's syndrome patients have varying concentration of certain proteins found in saliva. "This should allow us to diagnose patients more easily, to observe what actually happens to the salivary gland of patients with Sjogren's syndrome, to develop therapies to halt disease progression, to follow their progress during clinical trials, and to develop more effective saliva substitutes," Atkinson said.
'"/>




Page: 1

Related medicine news :

1. Early detection of prostate cancer
2. Early detection of heart attack
3. Early puberty linked to nutrition
4. Early Clue to Down Syndrome
5. Early delivery can prevent cancer
6. Early puberty more resistance
7. Early menopause- The cause
8. Early menopause- The cause
9. Early Warning System For Breast Cancer
10. Early therapy aids eyesight
11. Early detection of colorectal cancer may be hindered by coloured toilet disinfectants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology: